Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3006567	du-cl	— (—)	76	88	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other disorders of fluid, electrolyte and acid-base balance

32.61

61.24

1.2

—

Metabolic disorders

9.28

24.46

1.2

1.1

—

Disorders of other endocrine glands

6.84

6.89

1.1

—

Migraine

5.99

6.45

1.1

—

Cardiac arrhythmias

4.18

6.08

1.1

—

Endocrine, nutritional and metabolic diseases

7.88

5.70

1.4

1.2

—

Other heart diseases, wide

3.06

4.61

1.1

1.2

—

Migraine with aura

8.19

4.55

1.1

1.2

—

Other heart diseases

6.03

4.54

1.1

—

Benzodiazepine use

2.86

4.49

1.0

1.2

—

Diaphragmatic hernia

5.22

4.45

1.2

1.1

—

Hypertensive diseases

3.61

4.34

1.1

1.2

—

Hypertension

3.61

4.33

1.1

1.2

—

Implicit viral Sepsis

8.89

4.27

1.1

—

Viral Sepsis

8.89

4.27

1.1

—

Mood disorders, excluding more controls

3.07

4.18

1.1

—

Other arrhythmias

3.43

4.17

1.1

—

Any mental disorder

2.84

3.88

1.2

1.1

—

Anxiety disorders, excluding more controls

3.07

3.86

1.1

—

Hypertensive diseases (excluding secondary)

5.33

3.78

1.1

—

Hypertension, essential

3.40

3.77

1.1

1.2

—

Other diseases of intestines

2.71

3.75

1.4

1.1

—

Other noninfective gastroenteritis and colitis

6.15

3.49

1.6

1.1

—

Headache

2.99

3.48

1.2

1.1

—

Gastro-oesophageal reflux disease

2.82

3.42

1.1

—

Mood [affective] disorders

2.52

3.42

1.0

1.2

—

Mood disorders

2.52

3.41

1.0

1.2

—

Disorders of lacrimal system

4.07

3.38

1.1

—

Irritable bowel syndrome

5.72

3.34

1.0

1.1

—

Other disorders of lacrimal gland

4.35

3.30

1.1

—

Other functional intestinal disorders

4.22

3.19

1.0

1.1

—

Spondylopathies

2.62

3.10

1.3

1.1

—

Symptoms and signs involving the urinary system

2.79

3.07

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.53

3.03

1.1

—

Noninfective enteritis and colitis

3.54

2.98

1.6

1.1

—

Asthma (diagnoses ohter than nonallergic)

2.52

2.96

1.0

1.2

—

Depression

2.43

2.94

1.1

1.2

—

Asthma, excluding more controls

2.78

2.94

1.0

1.3

—

Abnormalities of breathing

2.60

2.87

1.1

1.2

—

Carbimazole or st.post thyroidectomy, condition for graves disease

5.39

2.86

1.0

—

Migraine without aura

6.67

2.86

1.0

1.1

—

Atrial fibrillation and flutter

7.78

2.84

1.0

—

Abnormalities of heart beat

4.01

2.82

1.0

—

Asthma

2.71

2.82

1.0

1.3

—

Asthma (mode)

2.68

2.79

1.0

1.3

—

Implicit Sepsis

2.63

2.78

1.1

—

Excessive earwax

3.25

2.72

1.2

1.1

—

Neurotic, stress-related and somatoform disorders

2.38

2.70

1.1

1.2

—

Migraine with aura and triptan purchases

6.00

2.69

1.2

1.1

—

Anxiety disorders

2.37

2.68

1.1

1.2

—

Disturbances of skin sensation

4.21

2.67

1.1

1.2

—

General symptoms and signs

2.38

2.62

1.4

1.1

—

Diseases of oesophagus, stomach and duodenum

2.26

2.60

1.2

—

Asthma, unspecified (mode), excluding more controls

3.17

2.56

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.45

2.55

1.5

1.1

—

Graves disease, strict definition

7.15

2.55

1.0

—

Thyrotoxicosis with diffuse goitre

5.46

2.54

1.0

—

Diseases of the digestive system

3.21

2.50

1.2

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.60

2.48

1.5

1.1

—

Asthma, unspecified (mode)

3.07

2.48

1.0

1.1

—

Intracranial trauma

3.09

2.47

1.1

1.3

—

Triptan medication for migraine, min. 3 purchases

2.77

2.47

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.26

2.43

1.2

1.1

—

Other reaction to severe stress, and adjustment disorders

3.64

2.36

1.1

1.0

—

Implicit viral Sepsis

3.64

2.36

1.1

—

Antihypertensive medication - note that there are other indications

3.67

2.36

1.1

1.4

—

ILD medications

2.17

2.34

1.5

1.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

6.92

2.33

1.2

1.0

—

Autoimmune diseases excluding thyroid diseases

2.32

2.30

1.5

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

3.19

2.29

1.1

1.3

—

All influenza

4.62

2.27

1.2

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2.74

2.25

1.0

1.1

—

Dyspnoea

2.20

2.23

1.1

—

Inflammatory bowel disease treatment related agents

2.11

2.22

1.5

1.1

—

Disorders of eyelid, lacrimal system and orbit

2.25

2.21

1.2

1.1

—

Nausea and vomiting

3.81

2.20

1.7

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.26

2.20

1.1

—

Atrial fibrillation and flutter with reimbursement

6.36

2.19

1.0

—

Recurrent or chronic depression

3.16

2.16

1.1

—

Use of pramipexole

4.29

2.15

1.2

1.1

—

Sulfasalazine

4.29

2.15

1.8

1.1

—

Nontoxic goitre/thyroid nodule

3.69

2.15

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

3.68

2.15

1.0

1.2

—

Senile cataract

2.63

2.13

1.2

1.1

—

Implicit Sepsis

2.28

2.13

1.1

—

Missing teeth due to accident, extraction or parodontitis

2.59

2.09

1.3

1.0

—

Sleep apnoea

2.16

2.08

1.1

1.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2.15

2.07

1.1

—

Migraine without aura and triptan purchases

5.00

2.07

1.0

1.1

—

Asthma (only as main-diagnosis), excluding more controls

2.48

2.05

1.0

1.3

—

Concussion

2.94

2.04

1.0

1.3

—

Hernia

2.19

2.04

1.2

—

Myalgia

4.00

2.04

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3.68

2.00

1.1

—

Substance abuse, excluding more controls

2.84

1.98

1.1

—

Asthma (only as main-diagnosis)

2.43

1.98

1.0

1.3

—

Cardiovascular diseases

3.02

1.97

1.7

1.1

—

Obesity related asthma

3.33

1.96

1.0

1.2

—

Urolithiasis

3.33

1.96

1.7

1.1

—

Sleep apnoea, including avohilmo

2.11

1.95

1.1

1.2

—

Exposure to unspecified factor

2.07

1.94

1.1

1.2

—

Extrapyramidal and movement disorders

2.96

1.93

1.1

—

Hyperparathyroidism

4.50

1.92

1.2

1.0

—

Pollen allergy

4.49

1.92

1.0

1.1

—

First line medication for Crohn's disease

2.01

1.90

1.5

1.1

—

Pain in throat and chest

2.27

1.89

1.2

—

Chronic lower respiratory diseases

1.97

1.89

1.0

1.2

—

Other symptoms and signs involving cognitive functions and awareness

2.91

1.88

1.0

1.1

—

Other diseases of the digestive system

3.18

1.88

1.1

1.0

—

Episodal and paroxysmal disorders

2.11

1.87

1.1

1.2

—

ILD medications: immunosuppressive drugs

2.32

1.87

1.7

1.1

—

Alcohol use disorder, ICD-based

2.86

1.86

1.0

1.1

—

All kidney diseases

2.04

1.85

1.4

1.1

—

Gastroduodenal ulcer

3.52

1.83

1.2

1.1

—

Personality disorders, excluding more controls

4.17

1.82

1.0

—

Bleeding

2.25

1.81

1.1

—

Disorders of parathyroid gland

4.12

1.80

1.2

1.0

—

Other arthritis (FG)

3.04

1.79

1.7

1.1

—

Disorders of thyroid, IBD co-morbidities

4.39

1.79

1.0

1.1

—

Influenza and pneumonia

1.97

1.78

1.1

1.2

—

Acetic acid derivatives and related substances

3.89

1.78

1.8

1.3

—

Other soft tissue disorders, not elsewhere classified

2.08

1.78

1.2

—

Other anxiety disorders

2.77

1.77

1.1

1.2

—

Exclusions for E4_PCOS_CONSORTIUM

2.26

1.77

1.1

—

Atopic dermatitis

2.37

1.75

1.1

—

Intestinal infectious diseases

2.07

1.74

1.4

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.92

1.72

1.0

1.1

—

Phlebitis and thrombophlebitis (not including DVT)

3.85

1.71

1.0

1.1

—

Valvular heart disease excluding rheumatic fever

2.75

1.71

1.3

1.1

—

Non-rheumatic valve diseases

2.75

1.71

1.3

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2.65

1.71

1.0

1.2

—

Pure hypercholesterolaemia

2.75

1.68

1.1

—

Asthma, including avohilmo

1.91

1.68

1.0

1.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.50

1.66

1.0

1.1

—

Thyrotoxicosis

3.16

1.66

1.0

1.1

—

Disorders of lens

2.27

1.65

1.2

1.1

—

All anxiety disorders

2.47

1.64

1.1

1.2

—

Vasomotor and allergic rhinitis

3.10

1.62

1.0

1.1

—

Care involving use of rehabilitation procedures

2.16

1.62

1.1

—

Other degenerative diseases of the nervous system

3.73

1.60

1.0

—

Nutritional anaemias

2.49

1.58

1.0

1.1

—

Anxiety (asthma-related co-morbidities)

2.34

1.58

1.1

1.3

—

Persons encountering health services for specific procedures and health care

1.92

1.57

1.1

1.2

—

Depression or dysthymia

2.33

1.56

1.1

—

Polyarthropathies

2.18

1.53

1.5

1.1

—

Hypothyroidism, strict autoimmune

2.26

1.53

1.0

1.1

—

L04AA Selective immunosuppressants

3.33

1.52

1.4

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.90

1.51

1.2

1.1

—

Other headache syndromes

2.59

1.51

1.0

1.1

—

GI-bleeding

2.86

1.50

1.2

1.0

—

Pain in joint

2.49

1.49

1.1

1.0

—

Iron deficiency anaemia

2.55

1.48

1.0

1.1

—

Benign neoplasm: Colon

2.45

1.48

1.2

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

2.06

1.47

1.1

—

Necrosis of pulp, including avohilmo

2.22

1.45

1.0

1.1

—

Atopic dermatitis, strict definition with reimbursement

2.76

1.44

1.2

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.88

1.44

1.4

1.1

—

Thyrotoxicosis, other and/or unspecified

3.13

1.44

1.0

1.1

—

Polyuria

3.13

1.44

1.0

1.1

—

Other extrapyramidal and movement disorders in other diseases

3.13

1.44

1.0

1.1

—

Impingement syndrome of shoulder

3.13

1.44

1.2

1.1

—

Alcohol dependence

3.13

1.44

1.0

1.1

—

Other viral diseases

3.12

1.43

1.2

—

Diverticular disease of intestine

2.19

1.43

1.2

1.1

—

Dizziness and giddiness

2.07

1.43

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.93

1.42

1.1

—

1.93

1.42

1.1

—

Syncope and collapse

2.50

1.42

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions

1.93

1.42

1.1

1.2

—

Other cataract

2.52

1.42

1.1

—

Examination and observation for other reasons

2.31

1.42

1.2

1.0

—

Hypothyroidism, other/unspecified

1.96

1.40

1.0

1.1

—

Mouth breathing

2.41

1.39

1.0

1.1

—

Substance abuse

2.23

1.38

1.1

1.3

—

Diseases of liver

2.61

1.36

1.2

1.1

—

Herpesviral [herpes simplex] infections

2.94

1.36

1.0

1.2

—

Autoimmune diseases

1.91

1.33

1.5

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

2.48

1.32

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.95

1.31

1.0

1.1

—

Diseases of salivary glands

2.50

1.30

1.2

1.1

—

Pneumonia, organism unspecified

1.89

1.30

1.1

1.2

—

Neurological diseases, wide definition

3.14

1.30

1.2

1.1

—

Reimbursement for rheumatic diseases

2.08

1.29

1.8

1.1

—

Mental and behavioural disorders due to psychoactive substance use

2.08

1.29

1.1

1.3

—

Intracranial injury

2.08

1.28

1.1

1.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2.36

1.28

1.1

—

Tramadol

1.95

1.28

1.2

1.1

—

Zoster [herpes zoster]

2.32

1.27

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.87

1.26

1.0

1.1

—

Any reimbursement code in KELA

2.36

1.26

1.0

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

2.06

1.26

1.2

1.1

—

Persons encountering health services in other circumstances, wide

1.75

1.25

1.4

1.1

—

Mental and behavioural disorders due to alcohol

2.26

1.25

1.0

1.3

—

Asthma, hospital admissions , main diagnosis only

1.88

1.25

1.0

1.2

—

Acute sinusitis

2.24

1.24

1.3

1.2

—

Abdominal and pelvic pain

1.90

1.23

1.4

1.1

—

Spontaneous abortion

2.25

1.23

1.0

1.1

—

Other abnormal products of conception

2.48

1.23

1.2

1.1

—

Diseases of the respiratory system

2.18

1.22

1.1

—

Personality disorders

2.63

1.21

1.0

1.2

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.79

1.21

1.1

1.2

—

Alcohol use disorder, Swedish definition

2.16

1.20

1.0

1.1

—

Ischaemic heart disease, wide definition

1.96

1.20

1.2

1.1

—

Allergic rhinitis

2.60

1.20

1.0

1.2

—

Constipation

1.83

1.20

1.0

1.1

—

Atopic dermatitis, strict definition

2.58

1.18

1.0

1.2

—

Other disorders of urethra and urinary system

1.98

1.18

1.0

1.1

—

Visual disturbances and blindness

2.10

1.18

1.0

1.1

—

Used for control exclusion in common control thyroid runs

1.86

1.17

1.6

1.1

—

Injuries to the shoulder and upper arm

1.90

1.17

1.1

1.2

—

Benign neoplasms

1.80

1.16

1.3

1.2

—

Melanocytic naevi

2.50

1.15

1.4

1.1

—

Inflammatory bowel disease

2.50

1.15

2.4

1.1

—

Other and unspecified iron deficiency

2.50

1.15

1.0

1.1

—

Injuries to the hip and thigh

2.35

1.12

1.0

1.1

—

2.01

1.12

1.0

1.3

—

Asthma/COPD (KELA code 203)

1.78

1.11

1.0

1.2

—

Other specified/unspecified arthritis

2.38

1.09

2.0

1.1

—

Calculus of kidney and ureter

2.38

1.09

2.0

1.1

—

Any dementia, excluding more controls

2.46

1.08

1.0

—

Other specific joint derangements/joint disorders

1.92

1.07

1.1

—

Other medical care

2.17

1.07

1.1

—

Malaise and fatigue

2.17

1.06

1.1

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.18

1.06

1.0

1.1

—

Cholelithiasis

1.79

1.06

1.1

—

Spondylosis

2.04

1.06

1.0

1.1

—

Disorders of skin appendages

2.12

1.05

1.3

—

Neurological diseases

1.88

1.05

1.1

1.3

—

Pneumonias (Asthma/COPD co-morbidities)

1.71

1.05

1.1

1.2

—

Primary open-angle glaucoma

2.30

1.04

1.0

—

Disorders of breast

1.99

1.04

1.0

1.1

—

Cholecystectomy

1.86

1.04

1.0

1.1

—

All pneumoniae

1.70

1.03

1.1

1.2

—

Glucagon-like peptide-1 (GLP-1) analogues

2.27

1.03

1.0

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2.27

1.03

1.0

1.1

—

Gestational [pregnancy-induced] hypertension

2.27

1.03

1.0

1.1

—

Basal cell carcinoma, including avohilmo

2.10

1.03

1.0

1.1

—

Heart failure, not strict

1.87

1.01

1.1

—

Asthma-related infections

2.02

1.00

1.0

1.1

—

Asthma, hospital admission 2, infections

2.02

1.00

1.0

1.1

—

Gastrointestinal diseases

2.06

0.99

1.0

1.1

—

Candidiasis

2.17

0.98

1.2

1.1

—

Intestinal stricture

2.17

0.98

2.4

1.0

—

Malignant neoplasm of skin

2.00

0.98

1.0

1.1

—

Other menopausal disorders

2.41

0.97

1.2

1.1

—

Coronary atherosclerosis

1.84

0.97

1.2

1.1

—

Visual disturbances

1.94

0.97

1.0

1.1

—

Rotator cuff syndrome

1.89

0.96

1.1

—

Disorders of gallbladder, biliary tract and pancreas

1.66

0.95

1.1

—

Ischemic heart diseases

1.73

0.95

1.2

1.0

—

Shoulder lesions

1.77

0.94

1.1

—

Other disorders of veins

2.21

0.93

1.8

1.1

—

Venous thromboembolism

1.88

0.93

1.1

—

Disorders of vitreous body

1.88

0.93

1.3

1.1

—

Ovarian cyst

2.16

0.91

1.0

1.1

—

Other and unspecified disorders of vitreous body

2.11

0.90

1.3

1.1

—

Temporomandibular joint disorders, including avohilmo

2.11

0.90

1.2

1.1

—

Psychiatric diseases

1.77

0.89

1.2

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.07

0.89

1.0

1.1

—

Aplastic and other anaemias

2.07

0.89

1.3

1.1

—

Unspecified haematuria

2.07

0.89

1.0

1.1

—

1.90

0.88

1.0

1.3

—

Symptoms and signs involving the circulatory and respiratory systems

1.71

0.88

1.2

—

Osteopathies and chondropathies

1.86

0.87

1.0

1.1

—

Percutaneous Coronary Intervention

1.71

0.85

1.2

1.0

—

Coronary revascularization (ANGIO or CABG)

1.71

0.85

1.2

1.0

—

Disorders of the thyroid gland

1.66

0.84

1.0

1.1

—

Cholelithiasis, broad definition with cholecystitis

1.65

0.83

1.1

—

Implicit bacterial Sepsis

1.92

0.83

1.3

1.1

—

L04AX Other immunosuppressants

1.74

0.82

1.3

1.1

—

Viral infections characterized by skin and mucous membrane lesions

1.87

0.81

1.2

1.1

—

Basal cell carcinoma

1.89

0.81

1.0

1.1

—

Second line medication for Crohn's disease

1.70

0.80

1.3

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.60

0.80

1.1

—

Female infertility

2.34

0.79

1.0

1.1

—

Chronic sinusitis

1.82

0.79

1.2

1.1

—

Oral corticosteroids

1.60

0.79

1.1

—

Sciatica+with lumbago

1.67

0.78

1.1

—

Pregnancy hypertension

1.79

0.77

1.0

1.1

—

Statin medication

1.69

0.75

1.1

1.3

—

Pain in limb

1.67

0.75

1.3

1.1

—

Acute upper respiratory infections

1.57

0.74

1.2

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

2.08

0.74

1.2

1.1

—

Spinal stenosis

1.83

0.73

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

1.63

0.73

1.6

1.1

—

Disorders of vitreous body and globe

1.82

0.73

1.3

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.54

0.72

1.5

1.1

—

Keratitis

2.00

0.72

1.2

1.1

—

Other viral diseases

1.98

0.72

1.2

1.1

—

Intestinal infectious diseases

1.53

0.72

1.0

1.1

—

Injuries to the knee and lower leg

0.57

0.70

1.0

1.2

—

Retinal detachments and breaks

1.92

0.70

1.0

1.1

—

In situ neoplasms

1.92

0.70

1.0

1.1

—

Any dementia

1.93

0.70

1.0

—

Sensorineural hearing loss

1.57

0.70

1.2

1.0

—

Other and unspecified dermatitis

1.71

0.69

1.3

1.1

—

Emergency coronary revascularization (for ACS)

1.59

0.67

1.2

1.1

—

Other diseases of lip and oral mucosa

1.79

0.66

1.2

1.1

—

Use of hypnotics and sedatives

1.52

0.65

1.1

—

Pain (limb, back, neck, head abdominally)

1.74

0.65

1.3

1.0

—

Implicit bacterial Sepsis

1.77

0.65

1.4

1.1

—

Other and unspecified anaemias

1.76

0.65

1.2

1.1

—

Other diseases of upper respiratory tract

1.52

0.65

1.1

—

Other anaemias

1.76

0.65

1.2

1.1

—

Sleep disorders (combined)

1.50

0.62

1.1

1.2

—

Noninflammatory disorders of female genital tract

1.88

0.61

1.2

1.1

—

Diseases of arteries, arterioles and capillaries

1.60

0.61

1.1

—

Later onset COPD

0.00

0.61

0.0

1.0

—

Explicit Sepsis

1.67

0.61

1.4

1.1

—

Non-selective monoamine reuptake inhibitors

1.66

0.61

1.2

1.1

—

0.00

0.61

0.0

1.0

—

Conjunctivitis

1.58

0.58

1.1

1.2

—

Excluding asthma or asthma-COPD overlap

1.62

0.58

1.1

1.3

—

Other pulmonary diagnosis

1.62

0.58

1.1

1.3

—

Gonarthrosis,primary

0.57

0.58

1.0

1.1

—

Disorders of vestibular function (Vertigo)

1.69

0.57

1.2

1.1

—

Nerve, nerve root and plexus disorders

1.45

0.56

1.1

—

Other antidepressants

1.48

0.55

1.1

1.2

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.60

0.55

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.46

0.54

1.5

1.1

—

Fever of other and unknown origin

1.57

0.54

2.2

1.0

—

Conductive and sensorineural hearing loss

1.45

0.53

1.2

1.0

—

COPD differential diagnosis

1.57

0.53

1.1

1.3

—

ILD differential diagnosis

1.57

0.53

1.1

1.3

—

Codes for special purposes

1.50

0.51

1.0

1.1

—

Provisional assignment of new diseases of uncertain etiology

1.50

0.51

1.0

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.50

0.51

1.0

1.2

—

Acute appendicitis

1.40

0.51

1.1

1.2

—

Diseases of inner ear

1.49

0.51

1.2

1.1

—

Angina pectoris

1.61

0.50

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

1.55

0.48

1.7

1.1

—

Finngen Rheumatological endpoints

1.45

0.48

1.6

1.1

—

Presence of other functional implants

1.52

0.48

1.0

1.1

—

Dermatitis and eczema

1.40

0.48

1.5

1.1

—

Irregular menses

1.49

0.48

1.0

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

1.46

0.47

1.4

1.0

—

Injuries to the head

1.39

0.46

1.1

1.2

—

Disorders of conjunctiva

1.45

0.46

1.1

1.2

—

Other disorders of ear

1.43

0.46

1.3

1.1

—

Any death

1.43

0.46

1.1

—

Fall on same level

1.39

0.46

1.1

1.2

—

Disease of hard tissues of teeth, NOS

1.49

0.44

1.3

1.1

—

Major coronary heart disease event

1.44

0.44

1.2

1.1

—

Peripheral artery disease

1.66

0.43

1.2

1.1

—

Dermatitis

1.37

0.43

1.3

1.1

—

Dementia

1.64

0.43

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.65

0.43

1.2

1.1

—

Other disorders of eyelid

1.59

0.42

1.4

1.1

—

Pregnancy with abortive outcome

1.39

0.42

1.0

1.1

—

Dementia, including avohilmo

1.56

0.42

1.0

—

Carpal tunnel syndrome

1.41

0.42

1.0

1.1

—

Presence of cardiac and vascular implants and grafts

1.55

0.42

1.0

1.1

—

1.36

0.42

1.2

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.55

0.42

1.0

1.1

—

Bacterial Sepsis

1.53

0.41

1.4

1.1

—

Inflammatory diseases of female pelvic organs

1.37

0.41

1.1

1.0

—

Medical treatment for female infertility

0.00

0.41

0.0

1.1

—

Colorectal adenocarcinoma

0.00

0.41

0.0

1.1

—

Endometriosis ASRM stages 1,2

0.00

0.41

0.0

1.1

—

Superficial injury of wrist and hand

0.00

0.41

0.0

1.1

—

Premature rupture of membranes

0.00

0.41

0.0

1.0

—

Pre-eclampsia

0.00

0.41

0.0

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.41

0.0

1.1

—

Poisoning by drugs, medicaments and biological substances

0.00

0.41

0.0

1.1

—

Suicide or other Intentional self-harm

0.00

0.41

0.0

1.1

—

Colorectal cancer

0.00

0.41

0.0

1.1

—

Certain infectious and parasitic diseases

1.40

0.40

1.1

—

Caries of dentine

0.00

0.40

0.0

1.1

—

Certain infectious and parasitic diseases

1.41

0.40

1.0

1.2

—

Neoplasms

1.40

0.40

1.2

—

Presence of other devices

0.00

0.40

0.0

1.1

—

Injuries to the ankle and foot

1.32

0.39

1.0

1.2

—

Any gastric operation

1.37

0.39

1.1

—

GASTRO-related operations

1.37

0.39

1.1

—

Organic, including symptomatic, mental disorders

1.42

0.39

1.0

1.1

—

Type 2 diabetes, wide definition

1.37

0.39

1.0

1.1

—

Other (not insulin) diabetes medications

1.35

0.38

1.1

—

Appendicitis, broad definition

1.33

0.38

1.1

1.2

—

Diseases of appendix

1.33

0.37

1.1

1.2

—

Cystitis

1.42

0.37

1.1

—

Coxarthrosis

1.47

0.36

1.2

1.1

—

Complications of procedures, not elsewhere classified

0.66

0.36

1.0

1.1

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.45

0.36

1.0

1.1

—

Contraceptive management

1.40

0.35

1.2

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.39

0.35

1.0

1.1

—

Allergic conjunctivitis

1.39

0.35

1.0

1.2

—

Other dorsopathies, not elsewhere classified

0.68

0.34

1.2

1.1

—

Coxarthrosis [arthrosis of hip](FG)

1.36

0.34

1.2

1.1

—

Artificial joint operation, meniscal resection

0.67

0.34

1.0

1.1

—

Acute appendicitis, no complications

1.33

0.33

1.2

—

Caries of enamel

0.67

0.33

1.2

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.32

0.33

1.0

1.1

—

Tonsillectomy and adenotomy

1.30

0.33

1.8

1.1

—

Disorders of sclera, cornea, iris and ciliary body

1.30

0.33

1.2

1.1

—

Other intervertebral disc disorders

1.37

0.32

1.0

1.1

—

Dental pulpitis, including avohilmo

0.72

0.31

1.0

1.2

—

Renal tubulo-interstitial diseases

1.35

0.31

1.2

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.33

0.31

1.1

—

Varicose veins

1.32

0.31

1.0

1.1

—

Other diseases of hard tissues of teeth

1.29

0.31

1.1

—

Autoimmune diseases related-to ILD

1.34

0.30

1.8

1.1

—

Symptoms and signs involving the digestive system and abdomen

1.35

0.29

1.6

1.1

—

Persons encountering health services in circumstances related to reproduction

1.24

0.29

1.9

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

1.29

0.28

1.1

—

Other nutritional deficiencies

1.30

0.28

1.1

—

Mycoses

1.32

0.27

1.1

1.2

—

Dentofacial anomalies [including malocclusion]

1.26

0.27

1.1

1.2

—

Low back pain

1.25

0.27

1.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.30

0.27

1.3

1.1

—

Triptan medication for migraine, single purchase ok

1.23

0.27

1.1

1.2

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.23

0.27

1.1

1.2

—

Complications of medical and surgical care

1.23

0.27

1.0

1.1

—

Other joint disorders

1.28

0.26

1.1

—

Arthropathies

1.23

0.26

1.6

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.38

0.24

1.2

1.0

—

Type 2 diabetes, strict (exclude DM1)

1.26

0.24

1.1

—

Type 2 diabetes, definitions combined

1.26

0.24

1.1

—

Selective serotonin reuptake inhibitors

1.28

0.23

1.1

1.2

—

Glaucoma

1.30

0.23

1.0

1.1

—

Open wound of head

1.30

0.23

1.0

1.2

—

Type 2 diabetes

1.25

0.23

1.1

—

Other bacterial diseases

1.25

0.23

1.6

1.1

—

Diabetes medication

1.25

0.22

1.1

1.2

—

Lower back pain or/and sciatica

1.24

0.22

1.1

—

Coxarthrosis, primary

1.21

0.22

1.2

1.1

—

Inguinal hernia

1.19

0.21

1.0

1.3

—

Impacted teeth

0.00

0.21

0.0

1.1

—

Diabetic retinopathy, strict definition

0.00

0.21

0.0

1.1

—

Embedded and impacted teeth

0.00

0.21

0.0

1.6

—

Mixed conductive and sensorineural hearing loss

0.00

0.21

0.0

1.1

—

Lichen planus

0.00

0.21

0.0

1.0

—

Malignant neoplasm of colon

0.00

0.21

0.0

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

0.00

0.21

0.0

1.1

—

Pediculosis, acariasis and other infestations

0.00

0.21

0.0

1.2

—

Pain in thoracic spine

0.00

0.21

0.0

1.1

—

D07AA Corticosteroids, weak (group I)

0.00

0.21

0.0

1.1

—

Radiculopathy

0.00

0.21

0.0

1.1

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

0.00

0.21

0.0

1.2

—

Ulcerative colitis (strict definition, require KELA)

0.00

0.21

0.0

1.2

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.21

0.0

1.2

—

Follicular cysts of skin and subcutaneous tissue

0.00

0.21

0.0

1.1

—

Other diseases of the respiratory system

0.00

0.21

0.0

1.1

—

Other respiratory disorders and diseases

0.00

0.21

0.0

1.1

—

Use of donepezil

0.00

0.21

0.0

1.0

—

Insulin, intermediate and long-acting

1.18

0.21

1.0

1.2

—

Chronic periodontitis, complicated

1.18

0.21

1.0

1.1

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.00

0.21

0.0

1.3

—

Malignant melanoma, including Hilmo

0.00

0.21

0.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.21

0.0

1.2

—

Nontraumatic intracranial haemmorrhage

0.00

0.21

0.0

1.1

—

Nonsuppurative otitis media

0.00

0.21

0.0

1.5

—

Hard cardiovascular diseases

1.27

0.21

1.2

1.1

—

Gingivitis and periodontal diseases

1.24

0.21

1.2

1.1

—

Lichen planus, including avohilmo

0.00

0.21

0.0

1.1

—

Sequelae with surgical and medical care as external cause

0.00

0.21

0.0

1.1

—

Poisoning by medicine

0.00

0.21

0.0

1.2

—

Later onset COPD, excluding more controls

0.00

0.20

0.0

1.1

—

Medical observation and evaluation for suspected diseases and conditions

1.23

0.20

1.2

1.0

—

0.00

0.20

0.0

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.21

0.20

1.3

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.20

0.0

1.1

—

Cellulitis

0.00

0.20

0.0

1.1

—

Acute tubulo-interstitial nephritis

1.18

0.19

1.2

1.1

—

Other diseases of urinary system

1.24

0.19

1.2

1.1

—

Codeine or tramadol medication

1.21

0.18

1.1

1.2

—

Erysipelas

1.21

0.18

1.0

1.1

—

Diseases of the eye and adnexa

1.17

0.18

1.1

1.3

—

Parasetamol

1.14

0.18

1.1

1.3

—

Appendectomy

1.17

0.18

1.1

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

1.15

0.17

1.0

1.2

—

Gonarthrosis [arthrosis of knee](FG)

0.75

0.17

1.0

1.1

—

Chronic diseases of tonsils and adenoids

1.20

0.17

1.6

1.1

—

Sleep disorders

1.22

0.17

1.2

—

Caries of dentine, including avohilmo

1.18

0.16

1.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.20

0.16

1.0

1.2

—

Malignant neoplasm

1.13

0.15

1.1

—

Biguanides

1.20

0.15

1.1

—

Insomnia

1.09

0.15

1.2

—

Injuries to the wrist and hand

0.81

0.14

1.0

1.2

—

COPD/asthma/ILD related infections

1.17

0.12

1.2

1.1

—

COPD/asthma related infections

1.17

0.12

1.2

1.1

—

Opioids

1.18

0.11

1.1

1.2

—

Dorsalgia

1.16

0.10

1.1

—

Insulin medication

1.11

0.10

1.0

1.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.09

0.09

1.0

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

1.15

0.09

1.0

1.2

—

Lumbar disc prolapse

1.10

0.09

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

1.07

0.08

1.3

1.1

—

Cerebrovascular diseases

1.03

0.08

1.0

1.1

—

Other neurological diseases

0.82

0.08

1.0

1.1

—

Obesity and other hyperalimentation

0.83

0.08

1.0

1.1

—

Obesity

0.83

0.08

1.0

1.1

—

External causes of morbidity and mortality

1.06

0.08

1.1

1.3

—

Disorders of choroid and retina

1.08

0.08

1.0

1.1

—

Artrosis, including avohilmo

1.04

0.08

1.0

1.1

—

Soft tissue disorders

1.14

0.08

1.1

1.2

—

Polycystic ovarian syndrome, consortium definition

1.10

0.08

1.0

1.1

—

Solid cancers, helper endpoint

1.03

0.07

1.0

1.1

—

Any event in cancer register

1.06

0.07

1.1

—

Diseases of the skin and subcutaneous tissue

1.13

0.07

1.3

1.1

—

Other bacterial diseases

1.04

0.07

1.2

—

Dorsopathies

0.88

0.07

1.6

1.1

—

Bronchitis

1.10

0.04

1.0

1.2

—

Falls/tendency to fall

1.10

0.04

1.1

1.2

—

Chronic periodontitis, including avohilmo

1.10

0.04

1.1

—

Periodontitis

1.10

0.03

1.1

—

Chronic apical periodontitis

0.92

0.03

1.1

1.2

—

Diseases of the ear and mastoid process

0.97

0.00

1.3

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

1.00

0.00

1.1

1.2

—

Diabetes mellitus

1.03

0.00

1.1

1.2

—

Diabetes, varying definitions

1.03

0.00

1.1

1.2

—

Amputation

0.00

0.0

1.2

—

Diabetic neuropathy

0.00

0.0

1.1

—

Injuries to unspecified part of trunk, limb or body region

0.00

0.0

1.0

—

Non-follicular lymphoma

0.00

0.0

1.0

—

Other condition

0.00

0.0

1.1

—

Malignant neoplasm of corpus uteri

0.00

0.0

1.0

—

Exposure to other specified factors

0.89

0.00

1.0

1.2

—

Nummular dermatitis

0.00

0.0

1.1

—

Sicca syndrome [Sjögren]

0.00

0.0

1.0

—

Malignant melanoma of skin, including Hilmo

0.00

0.0

1.1

—

Dermatophytosis

1.00

0.00

1.0

1.2

—

Certain conditions originating in the perinatal period

0.00

0.0

1.2

—

Cardiomyopathy

0.00

0.0

1.1

—

Chondropathies

0.00

0.0

1.1

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

0.0

1.0

—

Diseases of pulp and periapical tissues and dental caries

1.02

0.00

1.1

—

Other blood glucose lowering drugs, excl. Insulins

0.00

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

0.0

1.0

—

Secondary uncertain malignant neoplasm

0.00

0.0

1.1

—

Chalazion

0.00

0.0

1.0

—

Emotionally unstable personality disorder

0.00

0.0

1.2

—

Sudden idiopathic hearing loss

0.00

0.0

1.1

—

Dilated cardiomyopathy

0.00

0.0

1.2

—

Rash and other nonspecific skin eruption

0.00

0.0

1.0

—

Diseases of oral cavity, salivary glands and jaws

0.92

-0.00

1.2

1.1

—

Insulin, fast-acting (human)

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Stomach

0.00

-0.00

0.0

1.0

—

Embedded teeth, including avohilmo

0.00

-0.00

0.0

1.2

—

Dental caries, including avohilmo

0.92

-0.00

1.0

1.1

—

Suggestive for eosinophilic asthma

0.00

-0.00

0.0

1.2

—

Multiple gestation

0.00

-0.00

0.0

1.0

—

Cardiomyopathy (excluding other)

0.00

-0.00

0.0

1.1

—

Disorders of psychological development

0.00

-0.00

0.0

1.2

—

Other congenital malformations

0.00

-0.00

0.0

1.1

—

Peripheral artery operations in Hilmo

0.00

-0.00

0.0

1.2

—

Glomerulonephritis

0.00

-0.00

0.0

1.2

—

Other local infections of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Dermatophytosis

0.00

-0.00

0.0

1.1

—

Chronic suppurative otitis media, including avohilmo

0.00

-0.00

0.0

1.0

—

Arthropathic psoriasis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of head and neck

0.00

-0.00

0.0

1.2

—

Impacted cerumen

0.00

-0.00

0.0

1.0

—

Other maternal disorders predominantly related to pregnancy

1.02

-0.00

1.2

1.1

—

Myeloproliferative diseases

0.00

-0.00

0.0

1.0

—

COPD-related respiratory insufficiency

0.00

-0.00

0.0

1.0

—

Intracerebral haemorrhage

0.00

-0.00

0.0

1.0

—

Psoriatic arthropathies, ICD10

0.00

-0.00

0.0

1.0

—

Myocardial infarction, with ST-elevation

0.00

-0.00

0.0

1.1

—

Failed induction of labour

0.00

-0.00

0.0

1.2

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

-0.00

0.0

1.0

—

Other obstructed labour

0.00

-0.00

0.0

1.2

—

Glomerular diseases

0.00

-0.00

0.0

1.1

—

Congenital malformations of the urinary system

0.00

-0.00

0.0

1.0

—

Multiple delivery

0.00

-0.00

0.0

1.0

—

Acute nasopharyngitis (common cold)

0.00

-0.00

0.0

1.2

—

Dental operations

0.86

-0.00

1.0

1.1

—

Arthrosis

0.88

-0.00

1.0

1.1

—

Other psoriatic arthropathies

0.00

-0.00

0.0

1.0

—

Codeine

0.99

-0.00

1.1

1.2

—

Colon adenocarcinoma

0.00

-0.00

0.0

1.1

—

Benign neoplasm of major salivary glands

0.00

-0.00

0.0

1.0

—

Lesion of ulnar nerve

0.00

-0.00

0.0

1.2

—

Methotrexate

0.00

-0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

1.2

—

Other pleural conditions

0.00

-0.00

0.0

1.0

—

Other appendicitis

0.00

-0.00

0.0

1.2

—

Undefined dementia

0.00

-0.00

0.0

1.0

—

Idiopathic pulmonary fibrosis

0.00

-0.00

0.0

1.0

—

Other disorders of bladder

0.00

-0.00

0.0

1.2

—

Cholecystitis

0.00

-0.00

0.0

1.0

—

Benign neoplasm: salivary glands, exclude unknown (D119)

0.00

-0.00

0.0

1.0

—

Trochanteric bursitis

0.00

-0.00

0.0

1.0

—

Mucosal proctocolitis

0.00

-0.00

0.0

1.0

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.00

-0.00

0.0

1.2

—

Impacted maxillary molar

0.00

-0.00

0.0

1.2

—

Respiratory insufficiency

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of rectum, including Hilmo

0.00

-0.00

0.0

1.1

—

Other/unspecified synovitis and tenosynovitis

0.00

-0.00

0.0

1.0

—

Superficial injury of thorax

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of corpus uteri, including Hilmo

0.00

-0.00

0.0

1.0

—

Wet age-related macular degeneration

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

0.87

-0.00

1.0

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

0.00

-0.00

0.0

1.1

—

Other hammer toe(s) (acquired)

0.00

-0.00

0.0

1.1

—

Achilles tendinitis

0.00

-0.00

0.0

1.1

—

Hydrocele

0.00

-0.00

0.0

1.0

—

Injury of eye and orbit

0.00

-0.00

0.0

1.0

—

Leiomyoma of uterus

0.97

-0.00

1.0

1.1

—

Other complications of labour and delivery, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Thrombocytopenia, unspecified

0.00

-0.00

0.0

1.0

—

Childhood allergy (age < 16)

0.00

-0.00

0.0

2.2

—

Ankylosing spondylitis

0.00

-0.00

0.0

1.2

—

Twin gestation

0.00

-0.00

0.0

1.0

—

Haemangioma and lymphangioma, any site

0.00

-0.00

0.0

1.0

—

Unspecified dementia

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at lower leg level

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Cerebral meninges

0.00

-0.00

0.0

1.0

—

Otosclerosis

0.00

-0.00

0.0

1.0

—

Injury of unspecified body region

0.00

-0.00

0.0

1.0

—

Endometriosis of pelvic peritoneum

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

-0.00

0.0

1.0

—

Perforation of tympanic membrane

0.00

-0.00

0.0

1.0

—

Open wound of forearm

0.00

-0.00

0.0

1.0

—

Hydronephrosis

0.00

-0.00

0.0

1.0

—

Psoriatic and enteropathic arthropathies

0.00

-0.00

0.0

1.1

—

Psoriatic arthropathies

0.00

-0.00

0.0

1.2

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

-0.00

0.0

1.0

—

Polymyalgia rheumatica

0.00

-0.00

0.0

1.0

—

Decubitus ulcer and pressure area

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of bladder, including Hilmo

0.00

-0.00

0.0

1.1

—

Pleural effusion

0.00

-0.00

0.0

1.0

—

Other contact dermatitis

0.00

-0.00

0.0

1.0

—

Lichen sclerosus et atrophicus

0.00

-0.00

0.0

1.0

—

Vestibular neuronitis

0.00

-0.00

0.0

1.2

—

Accidents

0.88

-0.00

1.1

1.3

—

Hypermetropia

0.00

-0.00

0.0

1.0

—

Hordeolum and other deep inflammation of eyelid

0.00

-0.00

0.0

1.0

—

Scabies

0.00

-0.00

0.0

1.1

—

Subarachnoid haemorrhage

0.00

-0.00

0.0

1.0

—

Follow-up examination after treatment for malignant neoplasms

0.00

-0.00

0.0

1.0

—

Chronic suppurative otitis media

0.00

-0.00

0.0

1.0

—

Complications of surgical and medical care, not elsewhere classified

0.96

-0.00

1.0

1.1

—

Malignant neoplasm of ovary, including Hilmo

0.00

-0.00

0.0

1.0

—

Other/unspecified rheumatoid arthritis

0.00

-0.00

0.0

1.0

—

Other diseases of biliary tract

0.00

-0.00

0.0

1.0

—

Other external causes of accidental injury

0.88

-0.00

1.1

1.3

—

Malignant melanoma

0.00

-0.00

0.0

1.1

—

ILD, hospital admission 2, with pulmonary infections

0.00

-0.00

0.0

1.2

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

-0.00

0.0

1.0

—

Malignant melanoma of skin

0.00

-0.00

0.0

1.0

—

Pneumothorax

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in noncollision transport accidents

0.00

-0.00

0.0

1.0

—

Misadventures to patients during surgical and medical care

0.00

-0.00

0.0

1.0

—

ILD, hospital admissions 3, with pneumonia sepsis

0.00

-0.00

0.0

1.0

—

Other problems related to primary support group, including family circumstances

0.00

-0.00

0.0

1.2

—

Oral lichen planus, including avohilmo , including avohilmo

0.00

-0.00

0.0

1.0

—

Other specified/unspecified bacterial intestinal infections

0.00

-0.00

0.0

1.0

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

0.00

-0.00

0.0

1.0

—

Non-allergic asthma

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

1.0

—

Malignant neoplasm, wide definition for exclusion

0.96

-0.00

1.3

1.1

—

0.00

-0.00

0.0

1.2

—

Problems related to lifestyle

0.00

-0.00

0.0

1.2

—

Non-small cell lung cancer

0.00

-0.00

0.0

1.0

—

Use of rivastigmine

0.00

-0.00

0.0

1.0

—

Persons encountering health services for examination and investigation

1.00

-0.00

1.2

1.0

—

Personal history of malignant neoplasm

0.00

-0.00

0.0

1.0

—

Valvular operations

0.00

-0.00

0.0

1.1

—

Familial hypercholesterolemia

0.00

-0.00

0.0

1.2

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

1.2

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

-0.00

0.0

1.0

—

Special screening examination for other diseases and disorders

0.00

-0.00

0.0

1.0

—

Other specified/unspecified hearing loss

0.00

-0.00

0.0

1.0

—

Glomerular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.00

-0.00

0.0

1.1

—

Injuries to the elbow and forearm

0.96

-0.00

1.0

1.2

—

Cardiomyopathies, Primary/intrinsic

0.00

-0.00

0.0

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.01

-0.00

1.2

1.0

—

Other erythematous conditions

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of rectum

0.00

-0.00

0.0

1.2

—

Melanocytic naevi of trunk

0.00

-0.00

0.0

1.0

—

Tooth eruption problems

0.00

-0.00

0.0

1.1

—

Lung diseases due to external agents

0.00

-0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

0.00

-0.00

0.0

1.2

—

Myeloproliferative diseases (CML excluded)

0.00

-0.00

0.0

1.0

—

Congenital malformations of genital organs

0.00

-0.00

0.0

1.1

—

Retained placenta and membranes, without haemorrhage

0.00

-0.00

0.0

1.1

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.00

-0.00

0.0

1.1

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Chloride [Moles/time] in 24 hour Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS